Evaluation of immunologic enhancement mediated by a polysaccharide isolated from the fruit of Physalis alkekengi L. var. francheti (Mast.) Makino

Journal of Medicinal Plants Research

Volumn 5, Issue 5, 2011, Pages 784-790

  Li, Yonggang ^a   Han, Shuying ^a   Zhao, Hou ^a   Liu, Yali ^a   Fang, Jinbo ^a   Wang, Guiyun ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

Author keywords

Adjuvant; Cellular response; Herbal medicine; Humoral response; Polysaccharide

Indexed keywords

CONCANAVALIN A; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2B ANTIBODY; OVALBUMIN; PHYSALIS ALKEKENGI POLYSACCHARIDE; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; FRUIT; HEMOLYSIS; HUMORAL IMMUNITY; IMMUNOSTIMULATION; MALE; MOUSE; NONHUMAN; PHYSALIS; PHYSALIS ALKEKENGI; SPLEEN CELL;

MUS; PHYSALIS ALKEKENGI;

EID: 79955380887     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Ajdary S, Dobakhti F, Taghikhani M, Riazi-Rad F, Rafiei S, Rafiee- Tehrani M (2007). Oral administration of BCG encapsulated in alginate microspheres induces strong Th1 response in BALB/c mice. Vaccine, 25: 4595-4601.
2. Basey K, Woolley JG (1973). Alkaloids of Physalis alkekengi. Phytochemistry, 12: 2557-2559.
3. Chiarella P, Massi E, Robertis MD, Signori E, Fazio VM (2007). Adjuvants in vaccines and for immunisation: current trends. Expert. Opin. Biol. Ther., 7: 1551-1562.
4. Cox JC, Coulter AR (1997). Adjuvants--a classification and review of their modes of action. Vaccine, 15: 248-256.
5. Ebensen T, Guzmán CA (2008). Immune modulators with defined molecular targets: cornerstone to optimize rational vaccine design. Hum. Vaccin., 4:13-22.
6. Fang J, Wang G, Yang Q, Song J, Wang Y, Wang L (2005). The potential of phage display virions expressing malignant tumor specific antigen MAGE-A1 epitope in murine model. Vaccine, 23: 4860-4866.
7. Ge Y, Duan Y, Fang G, Zhang Y, Wang S (2009). Polysaccharides from fruit calyx of Physalis alkekengi var. francheti: Isolation, purification,v structural features and antioxidant activities. Carbohyd. Polym., 77: 188-193.
8. Giudice GD, Podda A, Rappuoli R (2002). What are the limits of adjuvanticity? Vaccine, 20: S38-41.
9. Guy B, Burdin N (2005). New adjuvants for parenteral and mucosal vaccines. Therapie, 60: 235-241.
10. Guy B. The perfect mix: recent progress in adjuvant research (2007). Nat. Rev. Microbiol. 5: 505-517.
11. Marciani DJ (2003). Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity. Drug Discov. Today, 8: 934-943.
12. McCluskie MJ, Weeratna RD (2001). Novel adjuvant systems. Curr. Drug Targets Infect. Disord., 1: 263-271.
13. Ooi VE, Liu F (2000). Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr. Med. Chem., 7: 715-729.
14. Perrie Y, Mohammed AR, Kirby DJ, McNeil SE, Bramwell VW (2008). Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigens. Int. J. Pharm., 364: 272-280.
15. Petrovsky N (2006). Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity. Vaccine, 24: 26-29.
16. Reed SG, Bertholet S, Coler RN, Friede M (2009). New horizons in adjuvants for vaccine development. Trends Immunol., 30: 23-32.
17. Schepetkin IA, Quinn MT (2006). Botanical polysaccharides: macrophage immunomodulation and therapeutic potential. Int. Immunopharmacol., 6: 317-333.
18. Seder RA, Paul WE (1994). Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol., 1: 635-673.
19. Silva DG, Cooper PD (2004). Petrovsky N. Inulin-derived adjuvants efficiently promote both Th1 and Th2 immune responses. Immunol. Cell. Biol., 82: 611-616.
20. Sun HX (2006). Haemolytic activities and adjuvant effect of Bupleurum chinense saponins on the immune responses to ovalbumin in mice. Vaccine, 24: 1324-1331.
21. Sun HX, XieY, Ye YP. Advances in saponin-based adjuvants (2009a). Vaccine, 27: 1787-1796.
22. Sun HX, Wang H, Xu HS, Ni Y (2009b). Novel polysaccharide adjuvant from the roots of Actinidia eriantha with dual Th1 and Th2 potentiating activity. Vaccine, 27: 3984-3991.
23. Sun JL, Hu YL, Wang DY, Zhang BK, Liu JG (2006). Immunologic enhancement of compound Chinese herbal medicinal ingredients and their efficacy comparison with compound Chinese herbal medicines. Vaccine, 24: 2343-2348.
24. Tong H, Liang Z, Wang G (2008). Structural characterization and hypoglycemic activity of a polysaccharide isolated from the fruit of Physalis alkekengi L. Carbohydr. Polym., 71: 316-323.
25. Vandepapelière P, Horsmans Y, Moris P, Van Mechelen M, Janssens M, Koutsoukos M, Van Belle P, Clement F, Hanon E, Wettendorff M, Garçon N, Leroux-Roels G (2008). Vaccine adjuvant system containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers. Vaccine, 26: 1375-1386.
26. Vessal M, Mehrani HA, Omrani GH (1991). Effects of an aqueous extract of Physalis alkekengi fruit on estrus cycle, reproduction and uterine creatine kinase BB-isozyme in rats. J. Ethnopharmacol., 34: 69-78.
27. Vessal M, Rasti M, Kooshesh F (1996). Modulation of the pituitary and basomedial hypothalamic lysyl-aminopeptidase activities by _- estradiol and/or an aqueous extract of Physalis Alkekengi fruits. Comp. Biochem. Physiol. B Biochem. Mol. Biol., 115: 267-271.
28. Wang D, Hu Y, Sun J, Kong X, Zhang B, Liu J (2005). Comparative study on adjuvanticity of compound Chinese herbal medicinal ingredients. Vaccine, 23: 3704-3708.
29. Wang D, Li X, Xu L, Hu Y, Zhang B, Liu J (2006). Immunologic synergism with IL-2 and effects of cCHMIs on mRNA expression of IL-2 and IFN-gamma in chicken peripheral T lymphocyte. Vaccine, 24: 7109-7114.
30. Wang G, Sun M, Fang J, Yang Q, Tong H, Wang L (2006). Protective immune responses against systemic candidiasis mediated by phagedisplayed specific epitope of Candida albicans heat shock protein 90 in C57BL/6J mice. Vaccine, 24: 6065-6073.
31. Wasser SP (2002). Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl. Microbiol. Biotechnol., 60: 258-274.
32. Xie G, Schepetkin IA, Quinn MT (2007). Immunomodulatory activity of acidic polysaccharides isolated from Tanacetum vulgare L. Int. Immunopharmacol., 7: 1639-1650.
33. Xie Y, Deng W, Sun H, Li D (2008). Platycodin D2 is a potential less hemolytic saponin adjuvant eliciting Th1 and Th2 immune responses. Int. Immunopharmacol., 8: 1143-1150.
34. Xie Y, Pan H, Sun H, Li D (2008). A promising balanced Th1 and Th2 directing immunological adjuvant, saponins from the root of Platycodon grandiflorum. Vaccine, 26: 3937-3945.
35. Yang L, Hu Y, Xue J, Wang F, Wang D, Kong X, Li P, Xu W (2008). Compound Chinese herbal medicinal ingredients can enhance immune response and efficacy of RHD vaccine in rabbit. Vaccine, 26: 4451-4455.
36. Yang Q, Wang L, Lu DN, Gao RJ, Song JN, Hua PY,Yuan DW (2005). Prophylactic vaccination with phage-displayed epitope of C. albicans elicits protective immune responses against systemic candidiasis in C57BL/6 mice. Vaccine, 23: 4088-4096.
37. Yang Z, Chen A, Sun H, Ye Y, Fang W (2007). Ginsenoside Rd elicits Th1 and Th2 immune responses to ovalbumin in mice. Vaccine, 25: 161-169.
38. Yang ZG, Sun HX, Fang WH (2005). Haemolytic activities and adjuvant effect of Astragalus membranaceus saponins (AMS) on the immune responses to ovalbumin in mice. Vaccine, 23: 5196-5203.
39. Zaharoff DA, Rogers CJ, Hance KW, Schlom J, Greiner JW (2007). Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination. Vaccine, 25: 2085-2094.
40. Zhang S, Zhang H, Zhao J (2009). The role of CD4 T cell help for CD8 TL activation. Biochem. Biophys. Res. Commun., 384: 405-408.
41. Zhou J, Wang L (1997). Analysis of nutrient composition in the fruit of Physalis alkekengi L. J. Nutr., 19: 243-245.